Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) — Cash Flow Reinvestment Rate
Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) has a Cash Flow Reinvestment Rate of 16.27x as of December 2023, reinvesting CN¥602.32 Million (capex CN¥70.15 Million plus investments CN¥-532.17 Million) from operating cash flow of CN¥37.03 Million. Check Shandong Keyuan Pharmaceutical Co. Ltd. cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shandong Keyuan Pharmaceutical Co. Ltd. A Cash Flow Reinvestment Rate (2021–2023)
Historical reinvestment intensity for Shandong Keyuan Pharmaceutical Co. Ltd. A across 3 annual periods. Explore 301281 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Shandong Keyuan Pharmaceutical Co. Ltd. A (2021–2023)
Year-by-year capital reinvestment analysis for Shandong Keyuan Pharmaceutical Co. Ltd. A. For live market cap and broader valuation context, see market cap of Shandong Keyuan Pharmaceutical Co. Ltd. .
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 16.27x | CN¥602.32 Million | CN¥37.03 Million | CN¥70.15 Million | ▲ +5958.1% |
| 2022 | 0.27x | CN¥31.11 Million | CN¥115.86 Million | CN¥31.11 Million | ▼ -30.8% |
| 2021 | 0.39x | CN¥20.19 Million | CN¥52.02 Million | CN¥20.19 Million | — |